| Efficacy of Pirfenidone Plus MODD in Diabetic Foot Ulcers (NCT02632877) | University of Guadalajara | 2014-01-01 |
| Preemptive Therapy of GVHD (NCT01994824) | University of Calgary | 2014-01-01 |
| A Phase 2 Extension Study of Study GCS-100-CS-4002 (NCT02155673) | La Jolla Pharmaceutical Company | 2014-01-01 |
| Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Lung Cancer (NCT02016209) | Zhejiang University | 2014-01-01 |
| Pilot Study Investigating the Feasibility of Determining the Endogenous Glucose Production During a Hypoglycaemia (NCT02028078) | Medical University of Graz | 2014-01-01 |
| Mesenchymal Stem Cells as a Treatment for Oral Complications of Graft-versus-host Disease (NCT02055625) | Karolinska Institutet | 2014-01-01 |
| Therapeutic Equivalence of OsvaRen® Tablets and OsvaRen® Granules (NCT02027662) | Fresenius Medical Care Deutschland GmbH | 2014-01-01 |
| Denosumab: A Potential Treatment Option for Aneurysmal Bone Cysts (NCT03415477) | Peking University People's Hospital | 2014-01-01 |
| Porous and Non-porous Bone Grafts in Intra-bony Periodontal Defects (NCT02463006) | Dr. D. Y. Patil Dental College & Hospital | 2014-01-01 |
| Non-invasive Current Stimulation for Restoration of Vision (NCT04008589) | University of Magdeburg | 2014-01-01 |
| Randomized Open-Label Study of INCB047986 in Subjects With Primary Myelodysplastic Syndrome (MDS) (NCT02093429) | Incyte Corporation | 2014-01-01 |
| Zinc as Enhancer in Immune Recovery After Stem Cell Transplantation for Hematological Malignancies (NCT03159845) | Azienda Ospedaliero, Universitaria Pisana | 2014-01-01 |
| Repetitive Intramyocardial CD34+ Cell Therapy in Dilated Cardiomyopathy (REMEDIUM) (NCT02248532) | University Medical Centre Ljubljana | 2014-01-01 |
| Study to Determine Efficacy and Safety of CC-486 With Nab-Paclitaxel Versus Nab-Paclitaxel in Patients With Chemotherapy naïve Metastatic Melanoma (NCT01933061) | Celgene Corporation | 2014-01-01 |
| Acarbose and Older Adults With Postprandial Hypotension (NCT01914133) | Kenneth Madden | 2014-01-01 |
| A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome (NCT01894958) | Neuren Pharmaceuticals Limited | 2014-01-01 |
| Efficacy of DCVAC/OvCa Plus Standard of Care in Relapsed Platinum Resistant Epithelial Ovarian Carcinoma (NCT02107378) | SOTIO a.s. | 2014-01-01 |
| The Activation on Prefrontal Cortex With Acupuncture and Moxibustion for Major Depressive Disorder: A Study of Functional Near Infrared Spectroscopy (NCT04272476) | Chengdu University of Traditional Chinese Medicine | 2014-01-01 |
| ED95 of Lidocaine 1.0% for Filling the Adductor Canal (NCT02033356) | Rigshospitalet, Denmark | 2014-01-01 |
| Effects of Vaginal Lactoferrin Administration Prior to Genetic Amniocentesis on Inflammatory Mediators (NCT02695563) | Università degli Studi di Ferrara | 2014-01-01 |
| Efficacy of Amlexanox vs. Placebo in Type 2 Diabetic Patients (NCT01975935) | University of Michigan | 2014-01-01 |
| Mesenchymal Stem Cell Administration in the Treatment of Coronary Graft Disease in Heart Transplant Patients (NCT02472002) | Assistance Publique - Hôpitaux de Paris | 2014-01-01 |
| A Phase 2 Trial of Regorafenib as A Single Agent in Advanced and Metastatic Biliary Tract Carcinoma/Cholangiocarcinoma Patients Who Have Failed First-line Chemotherapy (NCT02053376) | Nathan Bahary, MD | 2014-01-01 |
| Scheduling Nab-paclitaxel With Gemcitabine (NCT03529175) | CCTU- Cancer Theme | 2014-01-01 |
| Peripheral Blood Stem Cell Combined With Mesenchymal Stem Cells for Treatment of Poor Graft Function (NCT02083718) | Nanfang Hospital, Southern Medical University | 2014-01-01 |
| A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD (NCT02451696) | NYU Langone Health | 2014-01-01 |
| X Versus Placebo as Postoperative Adjuvant Treatment for Elder Breast Cancer (NCT02838238) | Peking Union Medical College Hospital | 2014-01-01 |
| Study to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD) (NCT01979016) | Regeneron Pharmaceuticals | 2013-12-31 |
| Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer (NCT01951586) | Amgen | 2013-12-31 |
| Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors (NCT01946529) | St. Jude Children's Research Hospital | 2013-12-27 |
| Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene (NCT01875237) | M.D. Anderson Cancer Center | 2013-12-27 |
| Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer (NCT02048020) | Jonsson Comprehensive Cancer Center | 2013-12-26 |
| Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma (NCT02017964) | Children's Oncology Group | 2013-12-24 |
| Safety and Efficacy Study of Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Metastatic Pancreatic Cancer (NCT02017015) | Celgene | 2013-12-24 |
| Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) (NCT01912274) | Helsinn Healthcare SA | 2013-12-24 |
| The Single Dose Pharmacokinetics of Two and Proof of Efficacy of One New Etoricoxib Gel Formulation in Participants With Osteoarthritis (MK-0663-168) (NCT01980940) | Organon and Co | 2013-12-23 |
| Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design (NCT02128906) | Christopher Wilke | 2013-12-23 |
| Tepotinib With Gefitinib in Participants With Locally Advanced or Metastatic NSCLC (INSIGHT) (NCT01982955) | Merck KGaA, Darmstadt, Germany | 2013-12-23 |
| Re-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone Metastases (NCT01934790) | Bayer | 2013-12-22 |
| An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Subjects With Alagille Syndrome (ALGS) (NCT02047318) | Mirum Pharmaceuticals, Inc. | 2013-12-20 |
| A Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers to Evaluate Efficacy and Safety in the Treatment of Autosomal-Dominant Alzheimer's Disease (AD), Including a Placebo-Treated Non-Carrier Cohort (NCT01998841) | Genentech, Inc. | 2013-12-20 |
| A Study to Assess the Effect of a Single Infusion of VAY736 on Disease Activity in Patients With Relapsing-remitting Multiple Sclerosis (NCT02038049) | Novartis Pharmaceuticals | 2013-12-20 |
| Efficacy and Safety Study of ME1111 in Patients With Onychomycosis (NCT02022215) | Meiji Seika Pharma Co., Ltd. | 2013-12-19 |
| Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells (NCT01779050) | Washington University School of Medicine | 2013-12-19 |
| Combining Ipilimumab, Degarelix, and Radical Prostatectomy in Men With Newly Diagnosed Metastatic Castration Sensitive Prostate Cancer or Ipilimumab and Degarelix in Men With Biochemically Recurrent Castration Sensitive Prostate Cancer After Radical Prostatectomy (NCT02020070) | Memorial Sloan Kettering Cancer Center | 2013-12-18 |
| Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris (NCT01930175) | Novartis Pharmaceuticals | 2013-12-18 |
| Study of Bacillus Calmette-Guerin (BCG) Combined With PANVAC Versus BCG Alone in Adults With High Grade Non-Muscle Invasive Bladder Cancer Who Failed At Least 1 Course of BCG (NCT02015104) | National Cancer Institute (NCI) | 2013-12-18 |
| Infiltration of the Vestibulum Vaginae With Botulin Toxin in Patients With Localized Provoked Vulvodynia (NCT01747161) | University Hospital, Ghent | 2013-12-17 |
| Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer (NCT02007512) | Pfizer | 2013-12-16 |
| Allo vs Hypomethylating/Best Supportive Care in MDS (BMTCTN1102) (NCT02016781) | Medical College of Wisconsin | 2013-12-16 |
| Study of Chemotherapy With Cisplatin/Carboplatin, and Docetaxel With or Without Erlotinib in Patients With Head and Neck Squamous Cell Carcinomas Amenable for Surgical Resection (NCT01927744) | M.D. Anderson Cancer Center | 2013-12-16 |
| A Study to Evaluate the Effect of Gefapixant (AF-219/MK-7264) on Methacholine Hyper-reactivity in Participants With Asthma (MK-7264-009) (NCT01993329) | Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2013-12-16 |
| Phase II Trial of Vandetanib in Children and Adults With Wild-Type Gastrointestinal Stromal Tumors (NCT02015065) | National Cancer Institute (NCI) | 2013-12-14 |
| A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study) (NCT02034916) | Pfizer | 2013-12-13 |
| Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer (NCT02012296) | University of Chicago | 2013-12-13 |
| Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe Asthma (NCT02054130) | MedImmune LLC | 2013-12-13 |
| Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma (NCT01993719) | National Cancer Institute (NCI) | 2013-12-12 |
| A Study of Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation (NCT01938625) | Janssen R&D Ireland | 2013-12-12 |
| Efficacy of ABI-007 Plus Gemcitabine or sLV5FU2 as First-line Therapy in Patients With Metastatic Pancreatic Cancer (NCT01964534) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2013-12-12 |
| Efficacy and Safety of High Dose Baclofen for Alcohol Dependence (NCT01980706) | University of North Carolina, Chapel Hill | 2013-12-12 |
| Window of Opportunity Study of VS-6063 (Defactinib) in Surgical Resectable Malignant Pleural Mesothelioma Participants (NCT02004028) | Verastem, Inc. | 2013-12-12 |
| CPT and Smoking Cessation (NCT01901848) | VA Office of Research and Development | 2013-12-11 |
| Proof of Concept of VLY-686 in Subjects With Treatment-Resistant Pruritus Associated With Atopic Dermatitis (NCT02004041) | Vanda Pharmaceuticals | 2013-12-10 |
| Regorafenib in Good Performance Status Patients With Newly Diagnosed Metastatic Colorectal Adenocarcinoma (NCT02023333) | Memorial Sloan Kettering Cancer Center | 2013-12-10 |
| Pilot Randomized Evaluation of Butyrate Irrigation Before Ileostomy Closure on the Colonic Mucosa in Rectal Cancer Patients (BUTYCLO) (NCT04795180) | Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta | 2013-12-10 |
| Comparison of Topical 0.15% Gancyclovir Gel Versus 0.3% Hypromellose Gel for the Treatment of Herpes Zoster Keratitis (NCT02382588) | Northwestern University | 2013-12-10 |
| A Phase 1B Dose-escalation and Phase 2a Study of Carotuximab (TRC105) in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma (NCT01975519) | Tracon Pharmaceuticals Inc. | 2013-12-10 |
| A Phase 2 Study of BGJ398 in Patients With Recurrent GBM (NCT01975701) | Novartis Pharmaceuticals | 2013-12-09 |
| Ibrutinib With or Without Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia (NCT02007044) | M.D. Anderson Cancer Center | 2013-12-06 |
| PH 2 ADI-PEG 20 Study in Non-Hodgkin's Lymphoma Subjects Who Have Failed Prior Systemic Therapy (NCT01910025) | Polaris Group | 2013-12-06 |
| A Long-Term Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency (NCT02004704) | Genzyme, a Sanofi Company | 2013-12-04 |
| Phase II Open Label Study Using Triheptanoin in Patients With Glucose Type 1 Transporter Deficiency GLUT1-DS (NCT02014883) | Institut National de la Santé Et de la Recherche Médicale, France | 2013-12-04 |
| Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy (NCT01871766) | St. Jude Children's Research Hospital | 2013-12-04 |
| Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors (NCT01962103) | Celgene | 2013-12-04 |
| Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis (NCT01865812) | Intercept Pharmaceuticals | 2013-12-03 |
| Evaluation of Different Dose Regimens of Aes-103 Given for 28 Days to Subjects With Stable Sickle Cell Disease (NCT01987908) | Baxalta now part of Shire | 2013-12-03 |
| Pilot Trial of Botulinum Toxin and Occupational Therapy for Writer's Cramp (NCT02015039) | National Institute of Neurological Disorders and Stroke (NINDS) | 2013-12-03 |
| Sorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With High-Risk Stage IIB-IV Soft Tissue Sarcoma (NCT02050919) | OHSU Knight Cancer Institute | 2013-12-03 |
| Cangrelor to Clopidogrel or Prasugrel Transition Study (NCT01979445) | The Medicines Company | 2013-12-02 |
| Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 Diabetes (NCT01923181) | Novo Nordisk A/S | 2013-12-02 |
| Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection (NCT01992276) | Crucell Holland BV | 2013-12-01 |
| Topical Application of Curcumin Orabase in Oral Submucous Fibrosis (OSMF) (NCT02645656) | SVS Institute of Dental Sciences | 2013-12-01 |
| Evaluation of Continuous Positive Airway Pressure for Tumor Motion Management in Radiotherapy (NCT02324530) | Sheba Medical Center | 2013-12-01 |
| Naltrexone for Individuals of East Asian Descent (NCT02026011) | University of California, Los Angeles | 2013-12-01 |
| Back on My Feet: Emotional Recovery From Fall Injury (NCT01998945) | Weill Medical College of Cornell University | 2013-12-01 |
| Sequential Paclitaxel Plus Cisplatin Chemotherapy and Radiotherapy as 1st Line Treatment for Esophageal Squamous Cell Cancer (NCT02016274) | Shen Lin | 2013-12-01 |
| A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer Patients (NCT02026583) | Samsung Medical Center | 2013-12-01 |
| The Effect of a Novel Dual-Task Exercise Program for Balance, Mobility and Cognition in Community Dwelling Older Adults (NCT01940055) | University of Manitoba | 2013-12-01 |
| A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma (NCT02014142) | Mati Therapeutics Inc. | 2013-12-01 |
| An Open Label Placebo Study To Assess The Inhalation Profile Obtained By Acoustic Monitoring In COPD Patients Using The NEXThaler DPI (NCT02018549) | Chiesi Farmaceutici S.p.A. | 2013-12-01 |
| Baclofen Effects on Marijuana Dependence (NCT02011516) | University of Pennsylvania | 2013-12-01 |
| Antibiotic Safety (SCAMP) (NCT01994993) | Michael Cohen-Wolkowiez | 2013-12-01 |
| Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus (NCT01958320) | University of California, San Francisco | 2013-12-01 |
| Safety Study of Mocetinostat in Combination With Azacitidine in Subjects With MDS (NCT02018926) | Mirati Therapeutics Inc. | 2013-12-01 |
| Safety and Efficacy of PG101 for Dry Eye Syndrome (NCT02078661) | Rhodes Pharmaceuticals, L.P. | 2013-12-01 |
| A Dose Escalating Study of SGX942 for Oral Mucositis in Patients With Head and Neck Cancer (NCT02013050) | Soligenix | 2013-12-01 |
| Plerixafor as a Salvage Regimen to Mobilize Allogeneic Stem Cells in Healthy Volunteers (NCT01954914) | Technische Universität Dresden | 2013-12-01 |
| Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus (NCT01972568) | EMD Serono | 2013-12-01 |
| Exploratory Study on the Use of Pregabalin for the Treatment of Taxol Related Arthralgia-Myalgia (NCT02024568) | Assaf-Harofeh Medical Center | 2013-12-01 |
| Possible Use of Rotigotine in Subjects 70 Years and Older With Late Onset of Disease (NCT02103465) | Azienda Ospedaliera Cardinale G. Panico | 2013-12-01 |